+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Polyglucose & Sodium Chloride Injection Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277831
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Polyglucose and Sodium Chloride Injection: Executive Overview

Polyglucose and sodium chloride injection combines a colloid component with isotonic saline to support intravascular volume and fluid replacement in appropriate clinical settings. Its use is shaped by hospital protocols, regulatory labeling, patient acuity, fluid-management practices, and the availability of alternative crystalloids and colloids. Clinical decisions require assessment of indication, contraindications, renal and cardiovascular status, electrolyte balance, and the product’s approved prescribing information.

Clinical Practice Is Shifting Toward More Deliberate Fluid Stewardship

Healthcare systems are placing greater emphasis on individualized fluid therapy, early reassessment, avoidance of unnecessary volume loading, and monitoring for electrolyte or circulatory complications. This shift favors products that can be incorporated into standardized protocols while supporting clear documentation of dose, patient selection, compatibility, and monitoring requirements. Supply resilience, quality assurance, and alignment with hospital formularies are also increasingly important to adoption and continued use.

Artificial Intelligence Strengthens Selection, Monitoring, and Supply Planning

Artificial intelligence can support this therapeutic area by combining electronic health-record data, laboratory results, hemodynamic observations, and medication histories to identify patients who may require closer fluid-management review. Predictive tools may assist with alerts for fluid overload, sodium abnormalities, renal deterioration, or reassessment intervals, but they should complement-not replace-clinical judgment. AI can also improve demand planning, inventory rotation, adverse-event signal detection, and manufacturing-quality analytics when governed by validated workflows, privacy controls, and human oversight.

Regional Insights: Regulation, Infrastructure, and Fluid-Management Practice Differ

North America generally emphasizes protocolized hospital care, electronic monitoring, and stringent product-quality expectations. Europe combines coordinated regulatory oversight with strong attention to evidence-based prescribing and medication safety. Asia-Pacific includes highly diverse healthcare systems, from advanced tertiary hospitals to resource-constrained settings, making accessibility, cold-chain or storage requirements, and clinician education important considerations. Latin America is influenced by public procurement, uneven hospital capacity, and import or local-manufacturing conditions. The Middle East often combines advanced urban medical centers with varying access across countries, while Africa’s use is closely linked to essential-medicine availability, infrastructure, affordability, and workforce capacity.

Group Insights: Economic and Security Blocs Shape Access and Standards

ASEAN markets reflect differing regulatory pathways, procurement systems, and levels of hospital capability, creating a need for adaptable registration and training strategies. BRICS members span major pharmaceutical and healthcare systems with distinct public-sector purchasing frameworks and domestic-production priorities. The European Union supports harmonized regulatory expectations while retaining national differences in reimbursement and hospital procurement. G7 systems typically apply rigorous safety, pharmacovigilance, and clinical-governance requirements. GCC countries often invest in advanced hospital infrastructure and centralized procurement, whereas NATO members represent diverse health systems whose common security concerns can heighten attention to medical supply continuity and emergency preparedness.

Country Insights: Local Protocols and Procurement Conditions Remain Decisive

Australia and Canada prioritize safety, hospital governance, and geographically resilient supply. Brazil, Mexico, India, China, Russia, and South Korea combine substantial healthcare demand with distinct regulatory, procurement, and domestic-manufacturing environments. France, Germany, Italy, Spain, and the United Kingdom emphasize evidence-based hospital use, pharmacovigilance, and institutional formularies, although reimbursement and purchasing arrangements differ. Japan places strong weight on regulatory compliance, clinical consistency, and careful product handling. Across the United States, adoption is influenced by hospital protocols, safety evaluation, supply reliability, and the requirements of diverse care settings. In every country, approved indications and local prescribing information remain foundational.

Action Priorities for Leaders: Build Evidence, Resilience, and Safe Use

Industry leaders should align product positioning with clearly defined clinical use cases, transparent safety information, and locally applicable regulatory requirements. They should strengthen supply continuity through qualified sourcing, contingency planning, quality-by-design controls, and robust serialization or traceability where required. Partnerships with hospitals can support protocol development, clinician education, and post-use monitoring. Digital tools should focus on decision support and surveillance rather than autonomous prescribing, with validation, cybersecurity, explainability, and accountability built into deployment. Regular review of clinical guidance and real-world safety signals can help maintain appropriate use.

Research Methodology: Evidence-Led Synthesis of Clinical and Market Context

This executive summary uses the supplied market definition-polyglucose and sodium chloride injection-and organizes implications across clinical practice, regulation, technology, geography, and healthcare-system structure. The assessment relies on established principles of intravenous fluid management, medication safety, hospital procurement, regulatory governance, and digital-health implementation. Regional, group, and country observations are presented as qualitative context rather than quantitative market claims. Product-specific decisions should be verified against current labels, official regulatory sources, clinical guidelines, institutional policies, and peer-reviewed evidence.

Conclusion: Responsible Integration Will Define the Opportunity

Polyglucose and sodium chloride injection sits within a fluid-therapy environment increasingly defined by patient selection, reassessment, safety monitoring, and operational resilience. Differences across regions, economic groups, and countries mean that a uniform approach is unlikely to be effective. Leaders that combine evidence-based clinical education, reliable quality systems, locally appropriate access strategies, and carefully governed analytics will be better positioned to support safe and consistent use. All implementation should remain subordinate to licensed indications, professional judgment, and applicable health regulations.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Polyglucose & Sodium Chloride Injection Market, by Product Type
7.1. Introduction
7.2. Combination Formulations
7.3. Polyglucose
7.4. Sodium Chloride Injection
8. Polyglucose & Sodium Chloride Injection Market, by Therapeutic Area/Setting
8.1. Introduction
8.2. Emergency Department
8.3. Intensive Care Units
8.3.1. Cardiac ICU
8.3.2. Medical ICU
8.3.3. Surgical ICU
8.4. Obstetrics And Gynecology
8.5. Oncology
8.6. Operating Room And Surgical Suites
8.7. Pediatrics And Neonatal
9. Polyglucose & Sodium Chloride Injection Market, by Packaging Type
9.1. Introduction
9.2. Ampoules
9.3. Bottles
9.4. IV Bags
9.4.1. 1000 Ml
9.4.2. 250 Ml
9.4.3. 50 Ml
9.4.4. 500 Ml
9.5. Multi-Dose Vials
9.6. Pre-Filled Syringes
10. Polyglucose & Sodium Chloride Injection Market, by Dosage Strength
10.1. Introduction
10.2. 0.45% Sodium Chloride
10.3. 0.9% Sodium Chloride
10.4. Custom And Compounded Strengths
10.5. Hypertonic Saline (3% And Above)
10.6. Polyglucose Concentrations
11. Polyglucose & Sodium Chloride Injection Market, by Formulation
11.1. Introduction
11.2. Concentrate And Reconstitutable
11.3. Multi-Dose
11.4. Ready-To-Use
11.5. Single-Use
12. Polyglucose & Sodium Chloride Injection Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics And Physician Offices
12.4. Dialysis And Specialty Centers
12.5. Home Healthcare
12.6. Hospitals
12.6.1. Medical Surgical
12.6.2. Specialty Hospitals
12.6.3. Teaching And Tertiary
12.7. Retail Pharmacies
13. Polyglucose & Sodium Chloride Injection Market, by Application/Indication
13.1. Introduction
13.2. Drug Dilution And IV Flush
13.3. Electrolyte Correction
13.4. Fluid Replacement And Resuscitation
13.5. Surgical Irrigation
13.6. Volume Expansion
13.6.1. Critical Care Volume Management
13.6.2. Intraoperative Volume Expansion
13.7. Wound Care And Irrigation
14. Polyglucose & Sodium Chloride Injection Market, by Distribution Channel
14.1. Introduction
14.2. Direct Manufacturer Sales
14.3. Hospital Tender And Procurement
14.3.1. Group Purchasing Organizations
14.3.2. Individual Hospital Procurement
14.3.3. National And Large-Scale Tenders
14.4. Online Pharmacies And E-Procurement
14.5. Retail Pharmacies And OTC
14.6. Wholesale Distributors
15. Polyglucose & Sodium Chloride Injection Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Polyglucose & Sodium Chloride Injection Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Polyglucose & Sodium Chloride Injection Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Ahlcon Parenterals India Ltd.
19.2. Akums Drugs & Pharmaceuticals Ltd.
19.3. Albert David Ltd.
19.4. B. Braun Melsungen AG
19.5. Baxter International Inc.
19.6. Biological E. Limited
19.7. Celon Laboratories Pvt. Ltd.
19.8. Ciron Drugs & Pharmaceuticals Pvt. Ltd.
19.9. Claris Lifesciences Ltd.
19.10. Denis Chem Lab Ltd.
19.11. Fresenius Kabi India Pvt. Ltd.
19.12. Gland Pharma Ltd.
19.13. Hetero Labs Ltd.
19.14. Hospira, Inc.
19.15. Intas Pharmaceuticals Ltd.
19.16. Kwality Pharmaceuticals Ltd.
19.17. Lupin Limited
19.18. Macleods Pharmaceuticals Ltd.
19.19. Neon Laboratories Ltd.
19.20. Nipro Corporation
19.21. Novartis AG
19.22. Otsuka Pharmaceutical Co., Ltd.
19.23. Pfizer Inc.
19.24. Sun Pharmaceutical Industries Ltd.
19.25. Terumo Corporation
19.26. Torrent Pharmaceuticals Ltd.
19.27. Viatris Inc.
19.28. Wockhardt Ltd.
19.29. Zydus Lifesciences Ltd.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Polyglucose & Sodium Chloride Injection Market, Years Considered for the Study
FIGURE 2. Global Polyglucose & Sodium Chloride Injection Market, Research Design
FIGURE 3. Global Polyglucose & Sodium Chloride Injection Market, Research Framework
FIGURE 4. Global Polyglucose & Sodium Chloride Injection Market, Data Triangulation
FIGURE 5. Global Polyglucose & Sodium Chloride Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2025 vs 2032 (%)
FIGURE 9. Global Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2025 vs 2032 (%)
FIGURE 11. Global Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2025 vs 2032 (%)
FIGURE 13. Global Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 15. Global Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Polyglucose & Sodium Chloride Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Polyglucose & Sodium Chloride Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2025 vs 2032 (%)
FIGURE 19. Global Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 21. Global Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Polyglucose & Sodium Chloride Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Polyglucose & Sodium Chloride Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Polyglucose & Sodium Chloride Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Polyglucose & Sodium Chloride Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Polyglucose & Sodium Chloride Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Polyglucose & Sodium Chloride Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Polyglucose & Sodium Chloride Injection Market Segmentation & Coverage
TABLE 2. Global Polyglucose & Sodium Chloride Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Combination Formulations Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Combination Formulations Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Combination Formulations Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Polyglucose Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Polyglucose Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Polyglucose Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Sodium Chloride Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Sodium Chloride Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Sodium Chloride Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 14. Global Emergency Department Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Emergency Department Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Emergency Department Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Intensive Care Units Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Intensive Care Units Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Intensive Care Units Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Cardiac ICU Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cardiac ICU Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cardiac ICU Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Medical ICU Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Medical ICU Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Medical ICU Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Surgical ICU Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Surgical ICU Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Surgical ICU Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Obstetrics And Gynecology Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Obstetrics And Gynecology Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Obstetrics And Gynecology Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Operating Room And Surgical Suites Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Operating Room And Surgical Suites Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Operating Room And Surgical Suites Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Pediatrics And Neonatal Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Pediatrics And Neonatal Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Pediatrics And Neonatal Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 42. Global Ampoules Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Ampoules Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Ampoules Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Bottles Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Bottles Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Bottles Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global IV Bags Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global IV Bags Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global IV Bags Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global 1000 Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global 1000 Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global 1000 Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global 250 Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global 250 Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global 250 Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global 50 Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global 50 Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global 50 Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global 500 Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global 500 Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global 500 Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Multi-Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Multi-Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Multi-Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Pre-Filled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Pre-Filled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Pre-Filled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 70. Global 0.45% Sodium Chloride Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global 0.45% Sodium Chloride Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global 0.45% Sodium Chloride Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global 0.9% Sodium Chloride Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global 0.9% Sodium Chloride Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global 0.9% Sodium Chloride Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Custom And Compounded Strengths Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Custom And Compounded Strengths Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Custom And Compounded Strengths Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Hypertonic Saline (3% And Above) Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Hypertonic Saline (3% And Above) Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Hypertonic Saline (3% And Above) Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Polyglucose Concentrations Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Polyglucose Concentrations Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Polyglucose Concentrations Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 86. Global Concentrate And Reconstitutable Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Concentrate And Reconstitutable Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Concentrate And Reconstitutable Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Multi-Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Multi-Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Multi-Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Ready-To-Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Ready-To-Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Ready-To-Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Single-Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Single-Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Single-Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Clinics And Physician Offices Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Clinics And Physician Offices Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Clinics And Physician Offices Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Dialysis And Specialty Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Dialysis And Specialty Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Dialysis And Specialty Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Home Healthcare Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Home Healthcare Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Home Healthcare Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Medical Surgical Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Medical Surgical Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Medical Surgical Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Specialty Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Specialty Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Specialty Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Teaching And Tertiary Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Teaching And Tertiary Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Teaching And Tertiary Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 127. Global Drug Dilution And IV Flush Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Drug Dilution And IV Flush Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Drug Dilution And IV Flush Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Electrolyte Correction Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Electrolyte Correction Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Electrolyte Correction Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Fluid Replacement And Resuscitation Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Fluid Replacement And Resuscitation Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Fluid Replacement And Resuscitation Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Surgical Irrigation Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Surgical Irrigation Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Surgical Irrigation Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Volume Expansion Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Volume Expansion Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Volume Expansion Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Critical Care Volume Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Critical Care Volume Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Critical Care Volume Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Intraoperative Volume Expansion Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Intraoperative Volume Expansion Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Intraoperative Volume Expansion Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Wound Care And Irrigation Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Wound Care And Irrigation Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Wound Care And Irrigation Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. Global Direct Manufacturer Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Direct Manufacturer Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Direct Manufacturer Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Hospital Tender And Procurement Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Hospital Tender And Procurement Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Hospital Tender And Procurement Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Group Purchasing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Group Purchasing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Group Purchasing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Individual Hospital Procurement Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Individual Hospital Procurement Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Individual Hospital Procurement Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global National And Large-Scale Tenders Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global National And Large-Scale Tenders Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global National And Large-Scale Tenders Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Online Pharmacies And E-Procurement Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Online Pharmacies And E-Procurement Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Online Pharmacies And E-Procurement Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Retail Pharmacies And OTC Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Retail Pharmacies And OTC Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Retail Pharmacies And OTC Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Wholesale Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Wholesale Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Wholesale Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Polyglucose & Sodium Chloride Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 182. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 183. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 184. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 185. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 187. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 188. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 189. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 190. Asia-Pacific Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 191. North America Polyglucose & Sodium Chloride Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 192. North America Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. North America Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 194. North America Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 195. North America Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 196. North America Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 197. North America Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 198. North America Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 199. North America Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. North America Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 201. North America Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 202. North America Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 203. North America Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 204. North America Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 205. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 208. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 209. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 210. Latin America Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 211. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 212. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 213. Latin America Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 215. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 216. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 217. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 218. Latin America Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 219. Europe Polyglucose & Sodium Chloride Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Europe Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Europe Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 222. Europe Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 223. Europe Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 224. Europe Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 225. Europe Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 226. Europe Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 227. Europe Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Europe Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 229. Europe Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 230. Europe Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 231. Europe Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. Europe Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 233. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 236. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 237. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 238. Middle East Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 239. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 240. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 241. Middle East Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 243. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 244. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 245. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 246. Middle East Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 247. Africa Polyglucose & Sodium Chloride Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 248. Africa Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 249. Africa Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 250. Africa Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 251. Africa Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 252. Africa Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 253. Africa Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 254. Africa Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 255. Africa Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Africa Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 257. Africa Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 258. Africa Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 259. Africa Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Africa Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 261. Global Polyglucose & Sodium Chloride Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 262. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 265. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 266. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 267. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 268. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 269. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 270. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 272. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 273. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 274. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 275. ASEAN Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 276. GCC Polyglucose & Sodium Chloride Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. GCC Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. GCC Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 279. GCC Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 280. GCC Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 281. GCC Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 282. GCC Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 283. GCC Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 284. GCC Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. GCC Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 286. GCC Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 287. GCC Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 288. GCC Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 289. GCC Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 290. European Union Polyglucose & Sodium Chloride Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. European Union Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. European Union Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 293. European Union Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 294. European Union Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 295. European Union Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 296. European Union Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 297. European Union Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 298. European Union Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. European Union Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 300. European Union Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 301. European Union Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 302. European Union Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 303. European Union Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 304. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 305. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 306. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 307. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 308. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 309. BRICS Polyglucose & Sodium Chloride Injection Market Size, by IV Bags, 2017-2032 (USD Million)
TABLE 310. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Dosage Strength, 2017-2032 (USD Million)
TABLE 311. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 312. BRICS Polyglucose & Sodium Chloride Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 314. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Application/Indication, 2017-2032 (USD Million)
TABLE 315. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Volume Expansion, 2017-2032 (USD Million)
TABLE 316. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 317. BRICS Polyglucose & Sodium Chloride Injection Market Size, by Hospital Tender And Procurement, 2017-2032 (USD Million)
TABLE 318. G7 Polyglucose & Sodium Chloride Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 319. G7 Polyglucose & Sodium Chloride Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 320. G7 Polyglucose & Sodium Chloride Injection Market Size, by Therapeutic Area/Setting, 2017-2032 (USD Million)
TABLE 321. G7 Polyglucose & Sodium Chloride Injection Market Size, by Intensive Care Units, 2017-2032 (USD Million)
TABLE 322. G7 Polyglucose & Sodium Chloride Injection Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 323. G7 Polyglucose & Sodium Chloride Injection

Companies Mentioned

  • Ahlcon Parenterals India Ltd.
  • Akums Drugs & Pharmaceuticals Ltd.
  • Albert David Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Biological E. Limited
  • Celon Laboratories Pvt. Ltd.
  • Ciron Drugs & Pharmaceuticals Pvt. Ltd.
  • Claris Lifesciences Ltd.
  • Denis Chem Lab Ltd.
  • Fresenius Kabi India Pvt. Ltd.
  • Gland Pharma Ltd.
  • Hetero Labs Ltd.
  • Hospira, Inc.
  • Intas Pharmaceuticals Ltd.
  • Kwality Pharmaceuticals Ltd.
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd.
  • Neon Laboratories Ltd.
  • Nipro Corporation
  • Novartis AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Terumo Corporation
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
  • Wockhardt Ltd.
  • Zydus Lifesciences Ltd.